Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 15,000 shares at $42.00 ($630K) on 2025-12-24, disclosed to the SEC on 2025-12-29.
Scheduled sale ($630k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |